Which of the following is a nonstimulant medication used in the treatment of ADHD?

Strattera, also known by its generic name atomoxetine, is recognized as a nonstimulant medication used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Unlike stimulant medications that primarily increase levels of dopamine and norepinephrine in the brain, Strattera works differently. It selectively inhibits the reuptake of norepinephrine, thereby increasing the availability of this neurotransmitter in the synaptic cleft and helping improve attention and focus in individuals with ADHD.

Nonstimulant medications are often preferred in certain situations, such as when there is a concern about a potential for substance misuse, or when a patient may not adequately respond to stimulant medications or experience undesirable side effects. Strattera can be taken once daily, providing a continuous effect over 24 hours, and is particularly helpful for individuals who may not respond well to traditional stimulants or have a history of anxiety, which can be exacerbated by stimulants.

In contrast, the other options listed—Adderall, Ritalin, and Vyvanse—are all classified as stimulant medications. These drugs primarily target the dopamine system to enhance concentration and reduce hyperactive behaviors, but they also come with potential side effects such as increased heart rate and anxiety. Thus,